A Phase II Study Investigating Upfront Pazopanib in Metastatic Clear Cell Renal Cancer [PANTHER].
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Jul 2014
At a glance
- Drugs Pazopanib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- Acronyms PANTHER
- 11 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Jun 2014 Planned End Date changed from 1 Feb 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 17 Oct 2012 Planned End Date changed from 1 Dec 2012 to 1 Feb 2013 as reported by ClinicalTrials.gov.